Effectiveness of dapagliflozin in nonalcoholic fatty liver disease in type 2 diabetes patients compared to sitagliptin and pioglitazone

被引：0
作者：
Koutsovasilis, A.
Sotiropoulos, A.
Bletsa, E.
Antoniou, A.
Tamvakos, C.
Ntionias, D.
Bousboulas, S.
Peppas, T.
机构：
[1] Gen Hosp Nikaia Piraeus, Dept Internal Med 3, Athens, Greece
[2] Gen Hosp Nikaia Piraeus, Ctr Diabet, Athens, Greece
来源：
DIABETOLOGIA | 2017年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
12
引用
收藏
页码：S7 / S8
页数：2
相关论文
共 50 条
[41]   Nonalcoholic fatty liver disease is a risk factor for CKD in patients with type 2 diabetes [J].
Nature Clinical Practice Gastroenterology & Hepatology, 2008, 5 (11) :593-593
[42]   Clinical effectiveness of sitagliptin compared with sulphonylureas for type 2 diabetes [J].
Sharma, Manuj ;
Nazareth, Irwin ;
Petersen, Irene .
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 :178-179
[43]   Noninvasive assessment of liver disease severity in patients with nonalcoholic fatty liver disease (NAFLD) and type 2 diabetes [J].
Pennisi, Grazia ;
Enea, Marco ;
Falco, Vincenzo ;
Aithal, Guruprasad P. ;
Palaniyappan, Naaventhan ;
Yilmaz, Yusuf ;
Boursier, Jerome ;
Cassinotto, Christophe ;
de Ledinghen, Victor ;
Chan, Wah Kheong ;
Mahadeva, Sanjiv ;
Eddowes, Peter ;
Newsome, Philip ;
Karlas, Thomas ;
Wiegand, Johannes ;
Wong, Vincent Wai-Sun ;
Schattenberg, Joern M. ;
Labenz, Christian ;
Kim, Won ;
Lee, Myoung Seok ;
Lupsor-Platon, Monica ;
Cobbold, Jeremy F. L. ;
Fan, Jian-Gao ;
Shen, Feng ;
Staufer, Katharina ;
Trauner, Michael ;
Stauber, Rudolf ;
Nakajima, Atsushi ;
Yoneda, Masato ;
Bugianesi, Elisabetta ;
Younes, Ramy ;
Gaia, Silvia ;
Zheng, Ming-Hua ;
Camma, Calogero ;
Anstee, Quentin M. ;
Mozes, Ferenc E. ;
Pavlides, Michael ;
Petta, Salvatore .
HEPATOLOGY, 2023, 78 (01) :195-211
[44]   Plasma Fatty Acid Composition Is Associated with Nonalcoholic Fatty Liver Disease in Type 2 Diabetes Patients [J].
Higa, Mariko ;
Ichijo, Takamasa .
DIABETES, 2022, 71
[45]   Nonalcoholic fatty liver disease: cause or consequence of type 2 diabetes? [J].
Valenti, Luca ;
Bugianesi, Elisabetta ;
Pajvani, Utpal ;
Targher, Giovanni .
LIVER INTERNATIONAL, 2016, 36 (11) :1563-1579
[46]   Nonalcoholic fatty liver disease and microvascular complications in type 2 diabetes [J].
Lv, Wen-Shan ;
Sun, Rui-Xia ;
Gao, Yan-Yan ;
Wen, Jun-Ping ;
Pan, Rong-Fang ;
Li, Li ;
Wang, Jing ;
Xian, Yu-Xin ;
Cao, Cai-Xia ;
Zheng, Ming .
WORLD JOURNAL OF GASTROENTEROLOGY, 2013, 19 (20) :3134-3142
[47]   Nonalcoholic Fatty Liver Disease and Type 2 Diabetes in Obese Children [J].
Lior Hecht ;
Ram Weiss .
Current Diabetes Reports, 2014, 14
[48]   Pharmacological management of nonalcoholic fatty liver disease in type 2 diabetes [J].
Cernea, Simona ;
Cahn, Avivit ;
Raz, Itamar .
EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2017, 10 (05) :535-547
[49]   Incidence of Type 2 Diabetes in Children With Nonalcoholic Fatty Liver Disease [J].
Newton, Kimberly P. ;
Wilson, Laura A. ;
Crimmins, Nancy A. ;
Fishbein, Mark H. ;
Molleston, Jean P. ;
Xanthakos, Stavra A. ;
Behling, Cynthia ;
Schwimmer, Jeffrey B. .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2023, 21 (05) :1261-1270
[50]   Nonalcoholic fatty liver disease and microvascular complications in type 2 diabetes [J].
Wen-Shan Lv ;
Rui-Xia Sun ;
Yan-Yan Gao ;
Jun-Ping Wen ;
Rong-Fang Pan ;
Li Li ;
Jing Wang ;
Yu-Xin Xian ;
Cai-Xia Cao ;
Ming Zheng .
World Journal of Gastroenterology, 2013, (20) :3134-3142
12345